COCP15/5OVERVIEW OF ACTIVITY To bridge the gap between research and patient care, this CME activity will use the perspectives of clinical investigators on key management challenges and controversies in the treatment of PC to assist medical oncologists, hematologists, hematology-oncology fellows, radiation oncologists, urologists and other healthcare practitioners in the formulation of up-to-date and appropriate treatment strategies. LEARNING OBJECTIVES
ACCREDITATION STATEMENT CME credit is no longer available for this issue CREDIT DESIGNATION STATEMENT CME credit is no longer available for this issue HOW TO USE THIS CME ACTIVITY CME credit is no longer available for this issue CONTENT VALIDATION AND DISCLOSURES FACULTY — The following faculty (and their spouses/partners) reported real or apparent conflicts of interest, which have been resolved through a conflict of interest resolution process: Andrew J Armstrong, MD, ScM Advisory Committee: Amgen Inc, Bayer HealthCare Pharmaceuticals, Bristol-Myers Squibb Company; Consulting Agreements: Active Biotech AB, AstraZeneca Pharmaceuticals LP, Dendreon Corporation, Ipsen, Sanofi; Contracted Research: Active Biotech AB, Astellas, Bristol-Myers Squibb Company, Dendreon Corporation, ImClone Systems, a wholly owned subsidiary of Eli Lilly and Company, Ipsen, Janssen Pharmaceuticals Inc, KangLaiTe USA, Medivation Inc, Novartis Pharmaceuticals Corporation, Pfizer Inc, Sanofi; Speakers Bureau: Amgen Inc, Dendreon Corporation, Pfizer Inc, Sanofi. Johann S de Bono, MBChB, MSc, PhD Advisory Committee and Consulting Agreements: Astellas Scientific and Medical Affairs Inc, AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals Inc, Genentech BioOncology, GlaxoSmithKline, Pfizer Inc, Sanofi; Contracted Research: Astellas Scientific and Medical Affairs Inc, AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals Inc, Genentech BioOncology, GlaxoSmithKline, Sanofi. Prof Ronald de Wit, MD, PhD Advisory Committee: Sanofi, Takeda Oncology; Consulting Agreements: Astellas Scientific and Medical Affairs Inc, Janssen Biotech Inc, Roche Laboratories Inc, Sanofi, Takeda Oncology; Contracted Research: Sanofi. Leonard G Gomella, MD Advisory Committee: Dendreon Corporation, GlaxoSmithKline; Consulting Agreements: Astellas Scientific and Medical Affairs Inc, Bayer HealthCare Pharmaceuticals, Janssen Biotech Inc; Contracted Research: Astellas Scientific and Medical Affairs Inc, Dendreon Corporation, Janssen Biotech Inc. Celestia S Higano, MD Advisory Committee: Abbott Laboratories, Astellas Scientific and Medical Affairs Inc, Bayer HealthCare Pharmaceuticals, Genentech BioOncology, Takeda Oncology; Consulting Agreements: Abbott Laboratories, Astellas Scientific and Medical Affairs Inc, Bayer HealthCare Pharmaceuticals, Dendreon Corporation, Genentech BioOncology, Medivation Inc, Pfizer Inc, Takeda Oncology; Contracted Research: Aragon Pharmaceuticals, AstraZeneca Pharmaceuticals LP, Dendreon Corporation, Genentech BioOncology, Medivation Inc, Sanofi, Takeda Oncology, Teva Oncology; Co-ownership: CTI BioPharma. None of the products currently approved or in development at CTI BioPharma pertain to any form of treatment for prostate cancer. As such, Dr Higano’s involvement with CTI BioPharma does not pose any conflict of interest in her participation in this CME activity. Philip Kantoff, MD Advisory Committee: Astellas Scientific and Medical Affairs Inc, Auven Therapeutics, Bellicum Pharmaceuticals Inc, BIND Therapeutics Inc, Blend Therapeutics, Endocyte/TRM Oncology, Medivation Inc, Metamark Genetics Inc, OncoCellMDx Inc, Progenics Pharmaceuticals Inc, Sanofi, SOTIO LLC, Tokai Pharmaceuticals Inc; Consulting Agreements: Amgen Inc, Aragon Pharmaceuticals Inc, Archimedes Pharma US Inc, Bayer HealthCare Pharmaceuticals, BN ImmunoTherapeutics Inc, Celgene Corporation, Dendreon Corporation, Exelixis Inc, Genentech BioOncology, Genomic Health Inc, GTx Inc, Janssen Biotech Inc, MorphoSys, OncoGenex Pharmaceuticals Inc, Pfizer Inc, Takeda Oncology, Teva Oncology/OncoGenex Pharmaceuticals Inc. Eric A Klein, MD Clinical Trial Support: Medivation Inc; Consulting Agreements: Genomic Health Inc, Medivation Inc; Contracted Research: Genomic Health Inc. Daniel P Petrylak, MD Consulting Agreements: Bayer HealthCare Pharmaceuticals, Bellicum Pharmaceuticals Inc, Dendreon Corporation, Ferring Pharmaceuticals, Johnson & Johnson Pharmaceuticals, Medivation Inc, Pfizer Inc, Sanofi, Takeda Oncology; Contracted Research: Celgene Corporation, Sanofi, Takeda Oncology; Grant Support: Dendreon Corporation, Johnson & Johnson Pharmaceuticals, OncoGenex Pharmaceuticals Inc, Progenics Pharmaceuticals Inc. A Oliver Sartor, MD Advisory Committee: Bayer HealthCare Pharmaceuticals, Sanofi; Consulting Agreements: Bavarian Nordic, Bayer HealthCare Pharmaceuticals, Biscayne Pharmaceuticals Inc, Medivation Inc, OncoGenex Pharmaceuticals Inc, Sanofi; Contracted Research: AstraZeneca Pharmaceuticals LP, Bayer HealthCare Pharmaceuticals, Progenics Pharmaceuticals Inc, Sanofi, Takeda Oncology. Neal D Shore, MD Consulting Agreements: Abbott Laboratories, Astellas Scientific and Medical Affairs Inc, Bayer HealthCare Pharmaceuticals, Ferring Pharmaceuticals, Genentech BioOncology, Genomic Health Inc, Pfizer Inc, Sanofi, Takeda Oncology. EDITOR — Dr Love is president and CEO of Research To Practice, which receives funds in the form of educational grants to develop CME activities from the following commercial interests: AbbVie Inc, Amgen Inc, Astellas Scientific and Medical Affairs Inc, AstraZeneca Pharmaceuticals LP, Aveo Pharmaceuticals, Bayer HealthCare Pharmaceuticals, Biodesix Inc, Biogen Idec, Boehringer Ingelheim Pharmaceuticals Inc, Boston Biomedical Pharma Inc, Bristol-Myers Squibb Company, Celgene Corporation, Clovis Oncology, Daiichi Sankyo Inc, Dendreon Corporation, Eisai Inc, Exelixis Inc, Foundation Medicine, Genentech BioOncology, Genomic Health Inc, Gilead Sciences Inc, ImmunoGen Inc, Incyte Corporation, Janssen Biotech Inc, Jazz Pharmaceuticals Inc, Lilly, Medivation Inc, Merck, Myriad Genetic Laboratories Inc, Novartis Pharmaceuticals Corporation, Novocure, Onyx Pharmaceuticals, an Amgen subsidiary, Pharmacyclics Inc, Prometheus Laboratories Inc, Regeneron Pharmaceuticals, Sanofi, Seattle Genetics, Sigma-Tau Pharmaceuticals Inc, Sirtex Medical Ltd, Spectrum Pharmaceuticals Inc, Taiho Oncology Inc, Takeda Oncology, Teva Oncology, Tokai Pharmaceuticals Inc and VisionGate Inc. RESEARCH TO PRACTICE STAFF AND EXTERNAL REVIEWERS — The scientific staff and reviewers for Research To Practice have no real or apparent conflicts of interest to disclose. This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantors. This activity is supported by educational grants from Astellas Scientific and Medical Affairs Inc/Medivation Inc, Bayer HealthCare Pharmaceuticals, Dendreon Corporation, Sanofi and Takeda Oncology. Hardware/Software Requirements: Last review date: July 2015 |